France, Germany, Italy, Spain and the UK currently hold 44 percent of the market share, while the US holds 22 percent and the Asia-Pacific region holds 32 percent.
Fecal occult blood tests currently account for 94 percent of the global market, but GlobalData predicts that novel blood tests will increase in use.
More Articles on Gastroenterology:
Strategies for Growing Patient Volume: 4 Gastroenterologists Discuss
How Does GI/Endoscopy Surgery Center Case Volume Compare to Other Specialties? 12 Statistics
National College of Natural Medicine Opens Center for IBS, SIBO Treatment
